Walmart Settles U.S. Government Lawsuit Over Opioid Dispensing Practices

Walmart Inc. has settled a lawsuit brought by the U.S. government that alleged the retailer's in-store pharmacies unlawfully dispensed controlled substances and helped fuel the nationwide opioid epidemic. The U.S. Department of Justice confirmed the agreement on Friday, though the specific terms were not made public.

Details of the Settlement

According to a statement from the Justice Department, the settlement resolves allegations that Walmart's pharmacies failed to meet their legal obligations in handling prescriptions for opioids and other powerful medications.

"The Department is pleased to have reached a settlement with Walmart resolving allegations that its pharmacies failed to comply with their obligations under the Controlled Substances Act in dispensing opioids and other controlled substances," a Justice Department spokesperson said in a statement cited by Reuters.

Ad

Context of the Allegations

The government's lawsuit accused Walmart of failing to properly screen questionable prescriptions, putting pressure on its pharmacists to fill them quickly. This conduct, the lawsuit alleged, constituted a violation of the Controlled Substances Act and contributed to the widespread public health crisis by dispensing addictive painkillers without sufficient oversight.

This settlement marks a significant development in the multi-year legal fallout from the opioid crisis, which has seen numerous lawsuits filed by federal, state, and local governments against drug manufacturers, distributors, and pharmacy chains. These legal actions have sought to hold companies financially accountable for their role in the epidemic, resulting in settlements totaling tens of billions of dollars across the industry.